Drug Discovery

We dive into the archive of 2023 for insight and inspiration – this time with Carl June.

DRAGONFLY deep learning meets de novo drug design – and Roche has already tested the approach

Could J&J’s combination treatment for PAH bridge the gaps between guidelines and practice, while easing the burden on patients?

Drug developers place their bets on the ROR-1 antigen in the battle against solid tumors.

Experts discuss the most exciting Alzheimer’s Disease treatment trends – and make bold predictions for the future

Progress in Alzheimer’s Disease research, but a cure will take time. Delaying it and disseminating that research may buy scientists the time they need

How – and why – we are tackling opioid use disorder with a monoclonal antibody

We interview Freya Biosciences' Colleen Acosta about the need for more therapies to address healthcare issues specific to women.

Acknowledging the monumental successes of the measles vaccine developer and “true giant” of science, medicine, and public health

Angelini Pharma launches crowdsourcing project to tackle drug-resistant epilepsy